Senescent Impairment in Synergistic Cytokine Pathways That Provide Rapid Cardioprotection in the Rat Heart

Journal of Experimental Medicine

Volumn 199, Issue 6, 2004, Pages 797-804

  Xaymardan, Munira ^a   Zheng, Jingang ^a   Duignan, Inga ^a   Chin, Andrew ^a   Holm, Jacquelyne M ^a   Ballard, Victoria L T ^a   Edelberg, Jay M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angiopoietin; Apoptosis; Myocardial infarction; Platelet derived growth factor; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CYTOKINE; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL LOSS; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DENSITY; DRUG POTENTIATION; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HEART BLOOD VESSEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART PROTECTION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RAT; SENESCENCE; SIGNAL TRANSDUCTION;

AGING; ANGIOPOIETIN-2; ANIMALS; CARDIOTONIC AGENTS; CELLS, CULTURED; CORONARY DISEASE; DNA PRIMERS; DRUG SYNERGISM; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, INBRED F344; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, TIE-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 1642313769     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031639     Document Type: Article

References (48)

1. Kass, D.A. 2002. Age-related changes in venticular-arterial coupling: pathophysiologic implications. Heart Fail. Rev. 7:51-62.
2. Lakatta, E.G., and D. Levy. 2003. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation. 107:139-146.
3. Halcox, J.P., W.H. Schenke, G. Zalos, R. Mincemoyer, A. Prasad, M.A. Waclawiw, K.R. Nour, and A.A. Quyyumi. 2002. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 106:653-658.
4. Gokce, N., J.F. Keaney, Jr., L.M. Hunter, M.T. Watkins, Z.S. Nedeljkovic, J.O. Menzoian, and J.A. Vita. 2003. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J. Am. Coll. Cardiol. 41:1769-1775.
5. Edelberg, J.M., S.H. Lee, M. Kaur, L. Tang, N.M. Feirt, S. McCabe, O. Bramwell, S.C. Wong, and M.K. Hong. 2002. Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart. Circulation. 105:608-613.
6. Edelberg, J.M., L. Tang, K. Hattori, D. Lyden, and S. Rafii. 2002. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ. Res. 90:E89-E93.
7. Rivard, A., L. Berthou-Soulie, N. Principe, M. Kearney, C. Curry, D. Branellec, G.L. Semenza, and J.M. Isner. 2000. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J. Biol. Chem. 275:29643-29647.
8. Edelberg, J.M., W.C. Aird, W. Wu, H. Rayburn, W.S. Mamuya, M. Mercola, and R.D. Rosenberg. 1998. PDGF mediates cardiac microvascular communication. J. Clin. Invest. 102:837-843.
9. Richardson, T.P., M.C. Peters, A.B. Ennett, and D.J. Mooney. 2001. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19:1029-1034.
10. Holash, J., P.C. Maisonpierre, D. Compton, P. Boland, C.R. Alexander, D. Zagzag, G.D. Yancopoulos, and S.J. Wiegand. 1999. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 284:1994-1998.
11. Ray, P.S., T. Estrada-Hernandez, H. Sasaki, L. Zhu, and N. Maulik. 2000. Early effects of hypoxia/reoxygenation on VEGF, ang-1, ang-2 and their receptors in the rat myocardium: implications for myocardial angiogenesis. Mol. Cell. Biochem. 213:145-153.
12. Patan, S. 2000. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J. Neurooncol. 50:1-15.
13. Carmeliet, P., M.G. Lampugnani, L. Moons, F. Breviario, V. Compernolle, F. Bono, G. Balconi, R. Spagnuolo, B. Oostuyse, M. Dewerchin, et al. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 98:147-157.
14. Neufeld, G., T. Cohen, S. Gengrinovitch, and Z. Poltorak. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB Journal January. 13:9-22.
15. Kim, I., J.H. Kim, S.O. Moon, H.J. Kwak, N.G. Kim, and G.Y. Koh. 2000. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene. 19:4549-4552.
16. Green, A.M., and N.D. Steinmetz. 2002. Monitoring apoptosis in real time. Cancer J. 8:82-92.
17. Hinescu, M.E. 2001. Cardiac apoptosis: from organ failure to allograft rejection. J. Cell. Mol. Med. 5:143-152.
18. Kovacs, P., I. Bak, L. Szendrei, M. Vecsernyes, E. Varga, I.E. Blasig, and A. Tosaki. 2001. Non-specific caspase inhibition reduces infarct size and improves post-ischaemic recovery in isolated ischaemic/reperfused rat hearts. Naunyn Schmiedebergs Arch. Pharmacol. 364:501-507.
19. Zou, Z., S. Sasaguri, K.G. Rajesh, and R. Suzuki. 2002. d1-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts. Am. J. Physiol. Heart Circ. Physiol. 283:H1968-H1974.
20. Cai, D., M. Xaymardan, J.M. Holm, J. Zheng, J.R. Kizer, and J.M. Edelberg. 2003. Age-associated impairment in TNF-alpha cardioprotection from myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 285:H463-H469.
21. Brooks, P.C., R.A. Clark, and D.A. Cheresh. 1994. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 264:569-571.
22. Dellian, M., B.P. Witwer, H.A. Salehi, F. Yuan, and R.K. Jain. 1996. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am. J. Pathol. 149: 59-71.
23. Aird, W.C., J.M. Edelberg, H. Weiler-Guettler, W.W. Simmons, T.W. Smith, and R.D. Rosenberg. 1997. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J. Cell Biol. 138: 1117-1124.
24. Matsunaga, T., D.C. Warltier, J. Tessmer, D. Weihrauch, M. Simons, and W.M. Chilian. 2003. Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. Am. J. Physiol. Heart Circ. Physiol. 285:H352-H358.
25. Silvestre, J.S., and B.I. Levy. 2002. Angiogenesis therapy in ischemic disease. Arch. Mal. Coeur Vaiss. 95:189-196.
26. Breier, G. 2000. Functions of the VEGF/VEGF receptor system in the vascular system. Semin. Thromb. Hemost. 26:553-559.
27. Risau, W. 1998. Development and differentiation of endothelium. Kidney Int. Suppl. 67:S3-S6.
28. Spyridopoulos, I., E. Brogi, M. Kearney, A.B. Sullivan, C. Cetrulo, J.M. Isner, and D.W. Losordo. 1997. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. J. Mol. Cell. Cardiol. 29:1321-1330.
29. Kim, I., S.O. Moon, C.Y. Han, Y.K. Pak, S.K. Moon, J.J. Kim, and G.Y. Koh. 2001. The angiopoietin-tie2 system in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosis. Cardiovasc. Res. 49:872-881.
30. Risau, W., and I. Flamme. 1995. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11:73-91.
31. Dejana, E., M.G. Lampugnani, O. Martinez-Estrada, and G. Bazzoni. 2000. The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability. Int. J. Dev. Biol. 44:743-748.
32. Blanc-Brude, O.P., J. Yu, H. Simosa, M.S. Conte, W.C. Sessa, and D.C. Altieri. 2002. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat. Med. 8:987-994.
33. Conway, E.M., F. Zwerts, V. Van Eygen, A. DeVriese, N. Nagai, W. Luo, and D. Collen. 2003. Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation. Am. J. Pathol. 163:935-946.
34. Hattori, K., S. Dias, B. Heissig, N.R. Hackett, D. Lyden, M. Tateno, D.J. Hicklin, Z. Zhu, L. Witte, R.G. Crystal, et al. 2001. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193:1005-1014.
35. Kalka, C., H. Masuda, T. Takahashi, W.M. Kalka-Moll, M. Silver, M. Kearney, T. Li, J.M. Isner, and T. Asahara. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA. 97:3422-3427.
36. Iwaguro, H., J. Yamaguchi, C. Kalka, S. Murasawa, H. Masuda, S. Hayashi, M. Silver, T. Li, J.M. Isner, and T. Asahara. 2002. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation. 105: 732-738.
37. Orlic, D., J. Kajstura, S. Chimenti, F. Limana, I. Jakoniuk, F. Quaini, B. Nadal-Ginard, D.M. Bodine, A. Leri, and P. Anversa. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA. 98:10344-10349.
38. Lipton, B.H., K.G. Bensch, and M.A. Karasek. 1991. Microvessel endothelial cell transdifferentiation: phenotypic characterization. Differentiation. 46:117-133.
39. Condorelli, G., U. Borello, L. De Angelis, D. Sirbella, M. Coletta, R. Galli, G. Balconi, A. Follenzi, G. Frati, M.G. Cusella De Angelis, et al. 2001. Cardiomyocytes induce endothelial cells to transdifferentiate into cardiac muscle: implications for myocardium regeneration. Proc. Natl. Acad. Sci. USA. 98:10733-10738.
40. Badorff, C., R.P. Brandes, R. Popp, S. Rupp, C. Urbich, A. Aicher, I. Fleming, R. Busse, A.M. Zeiher, and S. Dimmeler. 2003. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation. 107:1024-1032.
41. Shimizu, T., K. Kinugawa, A. Yao, Y. Sugishita, K. Sugishita, K. Harada, H. Matsui, O. Kohmoto, T. Serizawa, and T. Takahashi. 1999. Platelet-derived growth factor induces cellular growth in cultured chick ventricular myocytes. Cardiovasc. Res. 41:641-653.
42. Price, R.L., S.T. Haley, T.A. Bullard, E.C. Goldsmith, D.G. Simpson, T.E. Thielen, M.J. Yost, and L. Terracio. 2003. Effects of platelet-derived growth factor-AA and -BB on embryonic cardiac development. Anat. Rec. 272A:424-433.
43. Beltrami, A.P., L. Barlucchi, D. Torella, M. Baker, F. Limana, S. Chimenti, H. Kasahara, M. Rota, E. Musso, K. Urbanek, et al. 2003. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 114:763-776.
44. Higami, Y., and I. Shimokawa. 2000. Apoptosis in the aging process. Cell Tissue Res. 301:125-132.
45. Matz, R.L., C. Schott, J.C. Stoclet, and R. Andriantsitohaina. 2000. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol. Res. 49:11-18.
46. Yu, B.P., and H.Y. Chung. 2001. Oxidative stress and vascular aging. Diabetes Res. Clin. Pract. 54:S73-S80.
47. Hatake, K., E. Kakishita, I. Wakabayashi, N. Sakiyama, and S. Hishida. 1990. Effect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke. 21:1039-1043.
48. Harris, N.R., and R.E. Rumbaut. 2001. Age-related responses of the microcirculation to ischemia-reperfusion and inflammation. Pathophysiology. 8:1-10.